Support First Things by turning your adblocker off or by making a  donation. Thanks!

This editorial from Investor’s Business Daily is right on the money. Tremeondous progress is being made in adult/umbilical cord blood stem cells (which is why it gets more private funding), all but ignored by the media in their obsession to defeat the “heartless right wing Bible thumpers.” Good for IBD for seeing through the cloning obfuscation.


Comments are visible to subscribers only. Log in or subscribe to join the conversation.

Tags

Loading...

Filter First Thoughts Posts

Related Articles